Results 11 to 20 of about 139,828 (300)

Total lymphocyte count as a surrogate marker for CD4 count in resource-limited settings [PDF]

open access: yesBMC Infectious Diseases, 2012
Background CD4 testing is the recognized gold standard used to stage HIV/AIDS, guide treatment decisions for HIV-infected persons and evaluate effectiveness of therapy.
Obirikorang Christian   +2 more
doaj   +3 more sources

Comparing absolute lymphocyte count to total lymphocyte count, as a CD4 T cell surrogate, to initiate antiretroviral therapy

open access: yesJournal of Global Infectious Diseases, 2011
Background: The high cost of CD4 count estimation in resource-limited settings is a major obstacle in initiating patients on highly active antiretroviral therapy (HAART). Thus, there is a need to evaluate other less expensive surrogate markers like total
Srirangaraj Sreenivasan   +1 more
doaj   +3 more sources

Prediction of CD4+ T lymphocyte count in HIV patients from their total leukocyte count and previous CD4+ counts

open access: yesHIV & AIDS Review. International Journal of HIV-Related Problems
Introduction CD4+ T lymphocyte count is a high-cost para-clinical test, essential for follow-up of human immuno-deficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) patients.
Signed Esperanza Bohorquez Prieto   +2 more
doaj   +2 more sources

Physics of a rapid CD4 lymphocyte count with colloidal gold [PDF]

open access: yesCytometry Part A, 2011
AbstractThe inherent surface charges and small diameters that confer colloidal stability to gold particle conjugates (immunogold) are detrimental to rapid cell surface labeling and distinct cluster definition in flow cytometric light scatter assays.
P, Hansen   +6 more
openaire   +2 more sources

Predictions of CD4 lymphocytes’ count in HIV patients from complete blood count [PDF]

open access: yesBMC Medical Physics, 2013
يتطلب تشخيص فيروس نقص المناعة البشرية والتنبؤ به وعلاجه عدد الخلايا الليمفاوية T CD4 من قياس التدفق الخلوي، وهي تقنية باهظة الثمن غالبًا ما لا تتوفر للأشخاص في البلدان النامية. الهدف من هذا العمل هو تطبيق منهجية مطورة سابقة تتنبأ بقيمة الخلايا الليمفاوية التائية CD4 بناءً على إجمالي عدد خلايا الدم البيضاء (WBC) وعدد الخلايا الليمفاوية التي تطبق نظرية ...
Javier Rodríguez   +7 more
openaire   +2 more sources

The CD4+ T-lymphocyte count is an important predictor for the prognosis of cryptococcosis [PDF]

open access: yesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2016
There is great heterogeneity of immunity among patients with cryptococcosis, and severe immunodeficiency can lead to negative clinical outcomes. Underlying disease is a poor surrogate for immune status and inferior in predicting an individual's prognosis.
Ding, Y.   +8 more
openaire   +2 more sources

Immunological profile in persons under antiretroviral therapy in a rural Nigerian hospital

open access: yesJournal of Public Health in Africa, 2010
Human immunodeficiency virus (HIV) contributes significantly to morbidity and mortality in sub-Saharan Africa, with Nigeria having the third highest burden of HIV infection globally; efforts are made to increases access to HIV/AIDS care and treatment ...
Baba M. Musa   +6 more
doaj   +1 more source

Immune compromise in HIV-1/HTLV-1 coinfection with paradoxical resolution of CD4 lymphocytosis during antiretroviral therapy: a case report [PDF]

open access: yes, 2015
Human immunodeficiency virus type-1 (HIV-1) and human T lymphotropic virus type-1 (HTLV-1) infections have complex effects on adaptive immunity, with specific tropism for, but contrasting effects on, CD4 T lymphocytes: depletion with HIV-1, proliferation
Bangham, C   +6 more
core   +2 more sources

Absolute Lymphocyte Count Is Not a Suitable Alternative to CD4 Count for Determining Initiation of Antiretroviral Therapy in Fiji

open access: yesJournal of Tropical Medicine, 2014
Introduction. An absolute lymphocyte count is commonly used as an alternative to a CD4 count to determine initiation of antiretroviral therapy for HIV-infected individuals in Fiji when a CD4 count is unavailable. Methods.
Dashika A. Balak   +5 more
doaj   +1 more source

Combination immunotherapy induces distinct T-cell repertoire responses when administered to patients with different malignancies. [PDF]

open access: yes, 2020
BackgroundCTLA-4 blockade with ipilimumab is Food and Drug Administration-approved for melanoma as a monotherapy and has been shown to modulate the circulating T-cell repertoire.
Cham, Jason   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy